Skip to main content
. 2012 Feb 20;6:117–124. doi: 10.4137/CMO.S6248

Table 2.

Efficacy measures according to treatment group in the JMEN trial (Pemetrexed vs. Placebo as maintenance therapy).

Outcome value Pemetrexed
(N = 441)
Placebo
(N = 222)
P value
Response rate (% of patients) 6.8 1.8 0.05
Median overall survival (months) 13.4 10.6 0.012
Median progression free survival (months) 4.3 2.6 <0.0001